Bayer AG said on Thursday it has donated 3 million tablets of the
malaria drug Resochin to the U.S. government for potential use to treat
COVID-19.
Resochin, made of chloroquine phosphate and an approved treatment for
malaria, is being evaluated in China for its potential use against
COVID-19, the disease caused by the fast-spreading coronavirus.
Bayer said the drug is currently not approved for use in the United
States and the company is working with appropriate agencies on an
emergency use authorization for its use in the United States.
U.S. President Donald Trump, speaking at a news conference on
Thursday, called on U.S. health regulators to expedite potential
therapies such as Gilead Sciences Inc’s Remdesivir and the generic
antimalarial drug hydroxychloroquine, aimed at treating COVID-19.
https://www.reuters.com/article/us-health-coronavirus-bayer/bayer-donates-three-million-malaria-tablets-to-u-s-for-potential-use-against-coronavirus-idUSKBN21637E
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.